Determinants of PFOA Serum Half-Life after End of Exposure: A Longitudinal Study on Highly Exposed Subjects in the Veneto Region

Perfluoroalkyl substances (PFAS) are widely used, ubiquitous, and highly persistent man-made chemicals. Groundwater of a vast area of the Veneto Region (northeastern Italy) was found to be contaminated by PFAS from a manufacturing plant active since the late 1960s. As a result, residents were overex...

Full description

Saved in:
Bibliographic Details
Published inEnvironmental health perspectives Vol. 132; no. 2; p. 27002
Main Authors Batzella, Erich, Rosato, Isabella, Pitter, Gisella, Da Re, Filippo, Russo, Francesca, Canova, Cristina, Fletcher, Tony
Format Journal Article
LanguageEnglish
Published United States National Institute of Environmental Health Sciences 01.02.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Perfluoroalkyl substances (PFAS) are widely used, ubiquitous, and highly persistent man-made chemicals. Groundwater of a vast area of the Veneto Region (northeastern Italy) was found to be contaminated by PFAS from a manufacturing plant active since the late 1960s. As a result, residents were overexposed to PFAS through drinking water until 2013, mainly to perfluorooctanoic acid (PFOA). The aim of the present study was to estimate the rates of decline in serum PFOA and their corresponding serum half-lives, while characterizing their determinants. We investigated 5,860 subjects more than 14 years of age who enrolled in the second surveillance round of the regional health surveillance program. Two blood samples were collected between 2017 and 2022 (average time between measurements: 4 years). Serum PFOA excretion rates and half-lives were estimated based on linear mixed effect models, modeling subject-specific serum PFOA concentrations over time and correcting for background concentrations. For modeling determinants of half-life [age, sex, body mass index (BMI), smoking-habit, alcohol consumption, and estimated glomerular filtration rate (eGFR)], we added interaction terms between each covariate and the elapsed time between measurements. Perfluorooctanesulfonate (PFOS) and perfluorohexanesulfonic acid (PFHxS) apparent half-lives were also estimated. A separate analysis was conducted in children ( ). All analyses were stratified by sex. Median initial serum concentrations of PFOA was (range: 0.5-1,090), with a median reduction of 62.45%. The mean estimated PFOA half-life was 2.36 years [95% confidence interval (CI): 2.33, 2.40], shorter in women (2.04; 95% CI: 2.00, 2.08) compared to men (2.83; 95% CI: 2.78, 2.89). Half-lives varied when stratified by some contributing factors, with faster excretion rates in nonsmokers and nonalcohol drinkers (especially in males). This study, to our knowledge the largest on PFOA half-life, provides precise estimates in young adults whose exposure via drinking water has largely ceased. For other PFAS, longer half-lives than reported in other studies can be explained by some ongoing exposure to PFAS via other routes. https://doi.org/10.1289/EHP13152.
AbstractList Perfluoroalkyl substances (PFAS) are widely used, ubiquitous, and highly persistent man-made chemicals. Groundwater of a vast area of the Veneto Region (northeastern Italy) was found to be contaminated by PFAS from a manufacturing plant active since the late 1960s. As a result, residents were overexposed to PFAS through drinking water until 2013, mainly to perfluorooctanoic acid (PFOA).BACKGROUNDPerfluoroalkyl substances (PFAS) are widely used, ubiquitous, and highly persistent man-made chemicals. Groundwater of a vast area of the Veneto Region (northeastern Italy) was found to be contaminated by PFAS from a manufacturing plant active since the late 1960s. As a result, residents were overexposed to PFAS through drinking water until 2013, mainly to perfluorooctanoic acid (PFOA).The aim of the present study was to estimate the rates of decline in serum PFOA and their corresponding serum half-lives, while characterizing their determinants.OBJECTIVESThe aim of the present study was to estimate the rates of decline in serum PFOA and their corresponding serum half-lives, while characterizing their determinants.We investigated 5,860 subjects more than 14 years of age who enrolled in the second surveillance round of the regional health surveillance program. Two blood samples were collected between 2017 and 2022 (average time between measurements: 4 years). Serum PFOA excretion rates and half-lives were estimated based on linear mixed effect models, modeling subject-specific serum PFOA concentrations over time and correcting for background concentrations. For modeling determinants of half-life [age, sex, body mass index (BMI), smoking-habit, alcohol consumption, and estimated glomerular filtration rate (eGFR)], we added interaction terms between each covariate and the elapsed time between measurements. Perfluorooctanesulfonate (PFOS) and perfluorohexanesulfonic acid (PFHxS) apparent half-lives were also estimated. A separate analysis was conducted in children (n=480). All analyses were stratified by sex.METHODSWe investigated 5,860 subjects more than 14 years of age who enrolled in the second surveillance round of the regional health surveillance program. Two blood samples were collected between 2017 and 2022 (average time between measurements: 4 years). Serum PFOA excretion rates and half-lives were estimated based on linear mixed effect models, modeling subject-specific serum PFOA concentrations over time and correcting for background concentrations. For modeling determinants of half-life [age, sex, body mass index (BMI), smoking-habit, alcohol consumption, and estimated glomerular filtration rate (eGFR)], we added interaction terms between each covariate and the elapsed time between measurements. Perfluorooctanesulfonate (PFOS) and perfluorohexanesulfonic acid (PFHxS) apparent half-lives were also estimated. A separate analysis was conducted in children (n=480). All analyses were stratified by sex.Median initial serum concentrations of PFOA was 49 ng/mL (range: 0.5-1,090), with a median reduction of 62.45%. The mean estimated PFOA half-life was 2.36 years [95% confidence interval (CI): 2.33, 2.40], shorter in women (2.04; 95% CI: 2.00, 2.08) compared to men (2.83; 95% CI: 2.78, 2.89). Half-lives varied when stratified by some contributing factors, with faster excretion rates in nonsmokers and nonalcohol drinkers (especially in males).RESULTSMedian initial serum concentrations of PFOA was 49 ng/mL (range: 0.5-1,090), with a median reduction of 62.45%. The mean estimated PFOA half-life was 2.36 years [95% confidence interval (CI): 2.33, 2.40], shorter in women (2.04; 95% CI: 2.00, 2.08) compared to men (2.83; 95% CI: 2.78, 2.89). Half-lives varied when stratified by some contributing factors, with faster excretion rates in nonsmokers and nonalcohol drinkers (especially in males).This study, to our knowledge the largest on PFOA half-life, provides precise estimates in young adults whose exposure via drinking water has largely ceased. For other PFAS, longer half-lives than reported in other studies can be explained by some ongoing exposure to PFAS via other routes. https://doi.org/10.1289/EHP13152.CONCLUSIONSThis study, to our knowledge the largest on PFOA half-life, provides precise estimates in young adults whose exposure via drinking water has largely ceased. For other PFAS, longer half-lives than reported in other studies can be explained by some ongoing exposure to PFAS via other routes. https://doi.org/10.1289/EHP13152.
Background: Perfluoroalkyl substances (PFAS) are widely used, ubiquitous, and highly persistent man-made chemicals. Groundwater of a vast area of the Veneto Region (northeastern Italy) was found to be contaminated by PFAS from a manufacturing plant active since the late 1960s. As a result, residents were overexposed to PFAS through drinking water until 2013, mainly to perfluorooctanoic acid (PFOA). OBJECTIVES: The aim of the present study was to estimate the rates of decline in serum PFOA and their corresponding serum half-lives, while characterizing their determinants. Methods: We investigated 5,860 subjects more than 14 years of age who enrolled in the second surveillance round of the regional health surveillance program. Two blood samples were collected between 2017 and 2022 (average time between measurements: 4 years). Serum PFOA excretion rates and half-lives were estimated based on linear mixed effect models, modeling subject-specific serum PFOA concentrations over time and correcting for background concentrations. For modeling determinants of half-life [age, sex, body mass index (BMI), smoking- habit, alcohol consumption, and estimated glomerular filtration rate (eGFR)], we added interaction terms between each covariate and the elapsed time between measurements. Perfluorooctanesulfonate (PFOS) and perfluorohexanesulfonic acid (PFHxS) apparent half-lives were also estimated. A separate analysis was conducted in children (n = 480). All analyses were stratified by sex. Results: Median initial serum concentrations of PFOA was 49 ng/mL (range: 0.5- 1,090), with a median reduction of 62.45%. The mean estimated PFOA half-life was 2.36 years [95% confidence interval (CI): 2.33, 2.40], shorter in women (2.04; 95% CI: 2.00, 2.08) compared to men (2.83; 95% CI: 2.78, 2.89). Half-lives varied when stratified by some contributing factors, with faster excretion rates in nonsmokers and nonalcohol drinkers (especially in males). Conclusions: This study, to our knowledge the largest on PFOA half-life, provides precise estimates in young adults whose exposure via drinking water has largely ceased. For other PFAS, longer half-lives than reported in other studies can be explained by some ongoing exposure to PFAS via other routes.
Perfluoroalkyl substances (PFAS) are widely used, ubiquitous, and highly persistent man-made chemicals. Groundwater of a vast area of the Veneto Region (northeastern Italy) was found to be contaminated by PFAS from a manufacturing plant active since the late 1960s. As a result, residents were overexposed to PFAS through drinking water until 2013, mainly to perfluorooctanoic acid (PFOA). The aim of the present study was to estimate the rates of decline in serum PFOA and their corresponding serum half-lives, while characterizing their determinants. We investigated 5,860 subjects more than 14 years of age who enrolled in the second surveillance round of the regional health surveillance program. Two blood samples were collected between 2017 and 2022 (average time between measurements: 4 years). Serum PFOA excretion rates and half-lives were estimated based on linear mixed effect models, modeling subject-specific serum PFOA concentrations over time and correcting for background concentrations. For modeling determinants of half-life [age, sex, body mass index (BMI), smoking-habit, alcohol consumption, and estimated glomerular filtration rate (eGFR)], we added interaction terms between each covariate and the elapsed time between measurements. Perfluorooctanesulfonate (PFOS) and perfluorohexanesulfonic acid (PFHxS) apparent half-lives were also estimated. A separate analysis was conducted in children ( ). All analyses were stratified by sex. Median initial serum concentrations of PFOA was (range: 0.5-1,090), with a median reduction of 62.45%. The mean estimated PFOA half-life was 2.36 years [95% confidence interval (CI): 2.33, 2.40], shorter in women (2.04; 95% CI: 2.00, 2.08) compared to men (2.83; 95% CI: 2.78, 2.89). Half-lives varied when stratified by some contributing factors, with faster excretion rates in nonsmokers and nonalcohol drinkers (especially in males). This study, to our knowledge the largest on PFOA half-life, provides precise estimates in young adults whose exposure via drinking water has largely ceased. For other PFAS, longer half-lives than reported in other studies can be explained by some ongoing exposure to PFAS via other routes. https://doi.org/10.1289/EHP13152.
Audience Academic
Author Batzella, Erich
Rosato, Isabella
Russo, Francesca
Fletcher, Tony
Pitter, Gisella
Da Re, Filippo
Canova, Cristina
Author_xml – sequence: 1
  givenname: Erich
  orcidid: 0000-0001-6849-7920
  surname: Batzella
  fullname: Batzella, Erich
– sequence: 2
  givenname: Isabella
  surname: Rosato
  fullname: Rosato, Isabella
– sequence: 3
  givenname: Gisella
  surname: Pitter
  fullname: Pitter, Gisella
– sequence: 4
  givenname: Filippo
  surname: Da Re
  fullname: Da Re, Filippo
– sequence: 5
  givenname: Francesca
  surname: Russo
  fullname: Russo, Francesca
– sequence: 6
  givenname: Cristina
  surname: Canova
  fullname: Canova, Cristina
– sequence: 7
  givenname: Tony
  surname: Fletcher
  fullname: Fletcher, Tony
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38306197$$D View this record in MEDLINE/PubMed
BookMark eNqN0l1r2zAUBmAxOta0G-wXDMFgbBfu9GH5Y3ehS5dCIKXZeisU-9hRkaXUkqG520-fsjTrwnIxdGFhnvPC0Tln6MQ6Cwi9peSCsqL8PJneUE4Fe4FGVAiWlCVLT9CIkJImWZ6JU3Tm_T0hhBZZ9gqd8oKTjJb5CP38CgH6Tltlg8euwTdX8zFeQD90eKpMk8x0A1g1EeGJrbdi8rh2fujhCx7jmbOtDkMd6w1exMsGO4unul2ZzQ5CjRfD8h6qGK8tDivAd2AhOHwLrXb2NXrZKOPhzdP3HP24mny_nCaz-bfry_EsqQSjIakFF4SmwHNI0yJjJBOqypec58uCcWjqFGrCS0poCTkvgGWCKpGxCjKapg3wc_Rxl7vu3cMAPshO-wqMURbc4CUrGUvTssxJpO93tFUGpLaNC72qtlyO80JkQhS_VXJEtbG3Xpk4nkbH3wf-4oiPp4ZOV0cLPh0URBPgMbRq8F5eL27_387vDu2Hv-wKlAkr78wQ4jT8IXz39GTDsoNarnvdqX4j99vz3FLVO-97aGSlg9rmxNa0kZTI7XrK_Xo-D-FPwT7zH_oLMLjdkA
CitedBy_id crossref_primary_10_1016_j_envint_2024_108962
crossref_primary_10_3389_fpubh_2024_1418134
crossref_primary_10_3390_toxics12050314
crossref_primary_10_1289_EHP15486
crossref_primary_10_1016_j_ecoenv_2024_117395
crossref_primary_10_1289_EHP15099
Cites_doi 10.1111/j.1742-7843.2007.00155.x
10.7326/0003-4819-150-9-200905050-00006
10.1289/EHP5337
10.1002/9781118861769
10.1016/j.scitotenv.2022.156891
10.1111/j.1753-4887.2011.00446.x
10.1021/acs.est.2c05555
10.1039/d0em00291g
10.1136/oemed-2011-100288
10.1289/EHP6785
10.1016/j.envint.2022.107274
10.1289/ehp.0901252
10.1016/j.envint.2021.106415
10.1016/j.ijheh.2021.113757
10.1016/j.envint.2022.107198
10.1016/j.ijheh.2010.03.007
10.1021/es401905e
10.1038/s41370-018-0094-1
10.1039/c9em00497a
10.1016/j.envint.2017.06.007
10.1016/j.scitotenv.2015.01.070
10.1016/j.envint.2021.106789
10.1016/j.envint.2019.105220
10.1016/j.envint.2019.105381
10.1136/oemed-2017-104651
10.1289/EHP10103
10.1017/S1368980012000080
10.1016/j.envint.2012.12.014
10.1016/j.envint.2017.10.026
10.1016/j.ijheh.2022.114040
10.1021/es500796y
10.1021/acs.est.6b01477
10.1289/ehp.1510391
10.1007/s00420-007-0213-0
10.1002/etc.4890
10.1016/j.envres.2022.112674
10.1186/s12937-016-0180-y
10.2131/jts.28.49
10.1016/j.envint.2020.105581
10.1289/ehp.1306613
ContentType Journal Article
Copyright COPYRIGHT 2024 National Institute of Environmental Health Sciences
Copyright_xml – notice: COPYRIGHT 2024 National Institute of Environmental Health Sciences
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
7X8
DOI 10.1289/EHP13152
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1552-9924
ExternalDocumentID A785655870
38306197
10_1289_EHP13152
Genre Journal Article
GeographicLocations Italy
GeographicLocations_xml – name: Italy
GroupedDBID ---
-~X
.GJ
04C
29G
2WC
2XV
36B
3O-
42X
4P2
53G
5GY
5RE
5VS
6PF
7RV
7WY
7X7
7XC
85S
88E
8AO
8C1
8FE
8FG
8FH
8FI
8FJ
8FL
8G5
8R4
8R5
9K5
AACGO
AAFWJ
AANCE
AAWTL
AAYXX
ABBHK
ABDBF
ABJCF
ABOCM
ABPLY
ABPPZ
ABTLG
ABUWG
ABXSQ
ACGFO
ACHIC
ACIHN
ACIWK
ACNCT
ACPRK
ACUHS
ADBBV
ADOJX
ADQXQ
ADRAZ
ADULT
AEAQA
AENEX
AEUPB
AEUYN
AEXZC
AFKRA
AFPKN
AFRAH
AGNAY
AHDLI
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AN0
ANHSF
AOIJS
AQVQM
AS~
ATCPS
AXR
AZQEC
B0M
BAWUL
BCNDV
BENPR
BES
BEZIV
BGLVJ
BHPHI
BKEYQ
BKNYI
BMSDO
BNQBC
BPHCQ
BVXVI
C1A
CCPQU
CITATION
CS3
DCCCD
DIK
DU5
DWQXO
E3Z
EAD
EAP
EAS
EBC
EBD
EBS
EBX
ECF
ECGQY
ECT
EDH
EHB
EHC
EHE
EHN
EIHBH
EJD
EMB
EMK
EMOBN
EPL
EPT
ESX
EX3
F5P
F8P
FRNLG
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
H13
HCIFZ
HGD
HMCUK
HQ3
HTVGU
HYE
I-F
IAG
IAO
IEA
IEP
IER
IHR
IHW
INH
INR
IOF
IOV
IPO
IPSME
ISR
ITC
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
K60
K6~
K9-
KQ8
L6V
M0C
M0R
M1P
M2O
M48
M7S
NAPCQ
NEJ
O5R
O5S
OK1
OVT
P2P
PATMY
PCD
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQBIZ
PQBZA
PQGLB
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
Q2X
QF4
QM9
QN7
QO4
Q~Q
REH
RGD
RNS
RPM
RWL
RZL
S0X
SA0
SJN
SV3
TAE
TAN
TR2
TUS
U5U
UDP
UGJ
UKHRP
WH7
WOQ
WOW
WQ9
XSB
YR5
ZAC
ZE2
ZGI
~02
~8M
~KM
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7X8
ID FETCH-LOGICAL-c521t-d535014e37e44862065ac7b337b823efd4ed0391019e738e2651a562ce6144fe3
IEDL.DBID M48
ISSN 0091-6765
1552-9924
IngestDate Fri Jul 11 08:26:09 EDT 2025
Tue Jun 17 22:14:12 EDT 2025
Fri Jun 13 00:01:53 EDT 2025
Tue Jun 10 21:11:45 EDT 2025
Fri Jun 27 06:04:54 EDT 2025
Fri Jun 27 05:47:36 EDT 2025
Thu May 22 21:24:14 EDT 2025
Thu Apr 03 07:03:00 EDT 2025
Tue Aug 05 11:59:39 EDT 2025
Thu Apr 24 23:05:04 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c521t-d535014e37e44862065ac7b337b823efd4ed0391019e738e2651a562ce6144fe3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-6849-7920
OpenAccessLink https://ehp.niehs.nih.gov/doi/pdf/10.1289/EHP13152
PMID 38306197
PQID 2922449970
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2922449970
gale_infotracmisc_A785655870
gale_infotracgeneralonefile_A785655870
gale_infotracacademiconefile_A785655870
gale_incontextgauss_ISR_A785655870
gale_incontextgauss_IOV_A785655870
gale_healthsolutions_A785655870
pubmed_primary_38306197
crossref_citationtrail_10_1289_EHP13152
crossref_primary_10_1289_EHP13152
PublicationCentury 2000
PublicationDate 2024-02-00
2024-Feb
20240201
PublicationDateYYYYMMDD 2024-02-01
PublicationDate_xml – month: 02
  year: 2024
  text: 2024-02-00
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Environmental health perspectives
PublicationTitleAlternate Environ Health Perspect
PublicationYear 2024
Publisher National Institute of Environmental Health Sciences
Publisher_xml – name: National Institute of Environmental Health Sciences
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_41_2
e_1_3_2_40_2
e_1_3_2_20_2
e_1_3_2_43_2
e_1_3_2_21_2
e_1_3_2_42_2
e_1_3_2_22_2
e_1_3_2_23_2
e_1_3_2_24_2
e_1_3_2_25_2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_2_2
e_1_3_2_14_2
e_1_3_2_35_2
40085763 - Environ Health Perspect. 2025 Mar 14. doi: 10.1289/EHP17398.
References_xml – ident: e_1_3_2_34_2
  doi: 10.1111/j.1742-7843.2007.00155.x
– ident: e_1_3_2_16_2
  doi: 10.7326/0003-4819-150-9-200905050-00006
– ident: e_1_3_2_13_2
  doi: 10.1289/EHP5337
– ident: e_1_3_2_18_2
  doi: 10.1002/9781118861769
– ident: e_1_3_2_32_2
  doi: 10.1016/j.scitotenv.2022.156891
– ident: e_1_3_2_38_2
  doi: 10.1111/j.1753-4887.2011.00446.x
– ident: e_1_3_2_29_2
  doi: 10.1021/acs.est.2c05555
– ident: e_1_3_2_2_2
  doi: 10.1039/d0em00291g
– ident: e_1_3_2_40_2
  doi: 10.1136/oemed-2011-100288
– ident: e_1_3_2_8_2
  doi: 10.1289/EHP6785
– ident: e_1_3_2_31_2
  doi: 10.1016/j.envint.2022.107274
– ident: e_1_3_2_6_2
  doi: 10.1289/ehp.0901252
– ident: e_1_3_2_42_2
  doi: 10.1016/j.envint.2021.106415
– ident: e_1_3_2_9_2
  doi: 10.1016/j.ijheh.2021.113757
– ident: e_1_3_2_11_2
  doi: 10.1016/j.envint.2022.107198
– ident: e_1_3_2_19_2
  doi: 10.1016/j.ijheh.2010.03.007
– ident: e_1_3_2_26_2
  doi: 10.1021/es401905e
– ident: e_1_3_2_4_2
  doi: 10.1038/s41370-018-0094-1
– ident: e_1_3_2_10_2
  doi: 10.1039/c9em00497a
– ident: e_1_3_2_20_2
  doi: 10.1016/j.envint.2017.06.007
– ident: e_1_3_2_39_2
  doi: 10.1016/j.scitotenv.2015.01.070
– ident: e_1_3_2_23_2
  doi: 10.1016/j.envint.2021.106789
– ident: e_1_3_2_37_2
  doi: 10.1016/j.envint.2019.105220
– ident: e_1_3_2_7_2
  doi: 10.1016/j.envint.2019.105381
– ident: e_1_3_2_17_2
  doi: 10.1136/oemed-2017-104651
– ident: e_1_3_2_14_2
– ident: e_1_3_2_24_2
  doi: 10.1289/EHP10103
– ident: e_1_3_2_41_2
  doi: 10.1017/S1368980012000080
– ident: e_1_3_2_27_2
  doi: 10.1016/j.envint.2012.12.014
– ident: e_1_3_2_15_2
  doi: 10.1016/j.envint.2017.10.026
– ident: e_1_3_2_25_2
– ident: e_1_3_2_43_2
  doi: 10.1016/j.ijheh.2022.114040
– ident: e_1_3_2_28_2
  doi: 10.1021/es500796y
– ident: e_1_3_2_21_2
  doi: 10.1021/acs.est.6b01477
– ident: e_1_3_2_36_2
  doi: 10.1289/ehp.1510391
– ident: e_1_3_2_22_2
  doi: 10.1007/s00420-007-0213-0
– ident: e_1_3_2_3_2
  doi: 10.1002/etc.4890
– ident: e_1_3_2_12_2
  doi: 10.1016/j.envres.2022.112674
– ident: e_1_3_2_35_2
  doi: 10.1186/s12937-016-0180-y
– ident: e_1_3_2_33_2
  doi: 10.2131/jts.28.49
– ident: e_1_3_2_5_2
  doi: 10.1016/j.envint.2020.105581
– ident: e_1_3_2_30_2
  doi: 10.1289/ehp.1306613
– reference: 40085763 - Environ Health Perspect. 2025 Mar 14. doi: 10.1289/EHP17398.
SSID ssj0001866
Score 2.5255177
Snippet Perfluoroalkyl substances (PFAS) are widely used, ubiquitous, and highly persistent man-made chemicals. Groundwater of a vast area of the Veneto Region...
Background: Perfluoroalkyl substances (PFAS) are widely used, ubiquitous, and highly persistent man-made chemicals. Groundwater of a vast area of the Veneto...
SourceID proquest
gale
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 27002
SubjectTerms Alkanesulfonic Acids
Ammonium perfluorooctanoate
Analysis
Caprylates
Child
Drinking water
Drinking Water - chemistry
Environmental Exposure - analysis
Environmental Pollutants
Female
Fluorocarbons
Half-Life
Health aspects
Humans
Longitudinal Studies
Male
Water Pollutants, Chemical - analysis
Water, Underground
Young Adult
Title Determinants of PFOA Serum Half-Life after End of Exposure: A Longitudinal Study on Highly Exposed Subjects in the Veneto Region
URI https://www.ncbi.nlm.nih.gov/pubmed/38306197
https://www.proquest.com/docview/2922449970
Volume 132
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9NAEF71cUFCCMorUMIUIXoyrb2210GqqlAcAuojCqTKzXLs2apSsEsdS82Nn86M10nrKodefNnPkr3jmf1mPfuNEB9tO6WB_X1rQquP5RKhsAJXKkvL2HESFkjXvN9xcur3R-7PsTdeE4tum_UEFitTO-4nNbqefr75Oz8khz-otBGCzl7YH9iS1qF1sUnrkWL3PHFvNcNZ0s1oUdqWr3yvlqC9e2djUbofmu8Rzmrh6T0VT2rGCF1j4mdiDbMt8dhst4E5RfRc_Pt2p6wFcg2D3lkXKBCUf6AfT7V1fKkRqobgEGYpI8Kbq5y3B79AF45zbltUptwiC7i0cA55BlwDMp0bIKZAMYY3bQq4zIBoI5xTmJzlMEQuaX4hRr3w91HfqpsrWAn3MLBSr_qliFIhZWi-Q1QkTtRESkVWk6hTF1NWjycKiEoG6PieHRNZSpBTSI3ypdjI8gxfC0icGImHaSSuQtmlG7CR0ZXI9IDyvZbYXcxulNTK49wAYxpxBkJ2iBZ2aImdJfLKqG2swLxnA0XmnOjSQaOuCoicehR_WuJDhWB5i4zrZy7isiiiH2fnDwD9GjZAuzVI5_TESVyfWaD3ZtmsBvJTA3lhRMNXAbcbQPLmpDG8s_juIh7iErgM87KInA5NJ-WnjHllPsjlHMmAMj-7o9485KXeikcOMTNTer4tNmbXJb4jZjWbtMW6Giu6Bkc2X3vf22Lza3g6GLarvYp25Vj_AZdHIRw
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Determinants+of+PFOA+Serum+Half-Life+after+End+of+Exposure%3A+A+Longitudinal+Study+on+Highly+Exposed+Subjects+in+the+Veneto+Region&rft.jtitle=Environmental+health+perspectives&rft.au=Batzella%2C+Erich&rft.au=Rosato%2C+Isabella&rft.au=Pitter%2C+Gisella&rft.au=Re%2C+Filippo+Da&rft.date=2024-02-01&rft.pub=National+Institute+of+Environmental+Health+Sciences&rft.issn=0091-6765&rft.volume=132&rft.issue=2&rft_id=info:doi/10.1289%2FEHP13152&rft.externalDBID=ISR&rft.externalDocID=A785655870
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-6765&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-6765&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-6765&client=summon